Stephen DiPalma

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Stephen DiPalma

Stephen DiPalma was last confirmed as CFO at Spero Therapeutics, Inc. (SPRO) in a filing dated September 1, 2023. Earlier roles on record: CFO at Spero Therapeutics, Inc. (SPRO) until January 4, 2021.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Spero Therapeutics, Inc. (SPRO)
CFO

Proxy statement

Start not stated–2023-09-01

Last confirmed by a filing; no departure on record
Spero Therapeutics, Inc. (SPRO)
CFO

Proxy statement

Start not stated–2021-01-04

Company network

Recorded roles and call appearances connecting this person to public companies.

Spero Therapeutics, Inc.

SPRO

CFO

Recent activity

No call appearances or filed executive changes recorded yet.